Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhe Jiang Jian Feng Group Co Ltd's latest stock split occurred on Jan 21, 2003
The company executed a 3391-for-3204 stock split, meaning that for every 3204 shares held, investors received 3391 new shares.
The adjusted shares began trading on Jan 21, 2003. This was Zhe Jiang Jian Feng Group Co Ltd's 3rd stock split, following the previous one in Mar 4, 1998.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 24, 2026
|
|
Cue Biopharma Inc
NASDAQ:CUE
|
1-for-30
/30
|
0.5542 16.626 USD | 17.695 17.695 USD |
|
Apr 24, 2026
|
|
Medical Data Vision Co Ltd
TSE:3902
|
2-for-7253607
/3626803.5
|
1684 1684 JPY | N/A |
|
Apr 24, 2026
|
E
|
ESGL Holdings Ltd
NASDAQ:ESGL
|
1-for-3
/3
|
2.35 7.05 USD | 2.93 2.93 USD |
|
Apr 24, 2026
|
|
Metro Mining Ltd
ASX:MMI
|
1-for-20
/20
|
0.067 1.34 AUD | 1.3 1.3 AUD |
|
Apr 24, 2026
|
L
|
La Comer SAB de CV
OTC:LCMRF
|
115-for-114
x1.0087719298246
|
2.4715 2.4341 USD | 2.45 2.45 USD |
CUE
3902
MMI
Zhe Jiang Jian Feng Group Co Ltd
Glance View
Zhejiang Jianfeng Group Co. Ltd. engages in the manufacture and distribution of cement and other related products. The company is headquartered in Jinhua, Zhejiang and currently employs 2,072 full-time employees. The firm mainly conducts its cement business in Hubei Province, Yunnan Province, Zhejiang Province and Guangxi Province. The firm provides pharmaceuticals, including anti-infective drugs, antipyretic and analgesic drugs, drugs for cardiovascular system diseases, drugs for diabetes mellitus, bulk drugs, intermediates and over the counter (OTC) products. The firm is also engaged in the provision of health products, and the manufacture and distribution of cables. The firm conducts its business in domestic markets.
